top of page

How to Annotate Somatic Cancer Variants and Assess Their Prevalence with a Single Database

Thu, Apr 14

|

Webinar

In this webinar, we will introduce you to the Human Somatic Mutation Database (HSMD)—a new somatic database developed by QIAGEN that contains extensive genomic content relevant to solid tumors and hematological malignancies.

Registration is closed
See other events
How to Annotate Somatic Cancer Variants and Assess Their Prevalence with a Single Database
How to Annotate Somatic Cancer Variants and Assess Their Prevalence with a Single Database

Time & Location

Apr 14, 2022, 8:00 AM PDT

Webinar

About the event

Across oncology applications, from research to molecular testing and pharmaceutical development, the ability to identify potentially actionable genetic alterations and exploit the molecular vulnerabilities of cancer is becoming increasingly difficult. Due to the sporadic nature of somatic cancers, the number of detected variants is exponentially growing, challenging scientists to confidently identify meaningful mutations that could influence or improve decisions in experimental design, at point-of-care, or in drug development.

In this webinar, we will introduce you to the Human Somatic Mutation Database (HSMD)—a new somatic database developed by QIAGEN that contains extensive genomic content relevant to solid tumors and hematological malignancies. Available as a web-based application, this expert-curated resource contains content from over 300,000 real-world clinical oncology cases combined with content from the QIAGEN Knowledge Base, providing gene-level, alteration-level, and disease-level information including clinically observed gene and variant frequencies across diseases. Users can easily search and explore mutational characteristics across genes,…

Share this event

bottom of page